Litigation Details for Amarin Pharma, Inc. v. Apotex, Inc. (N.D. Ill. 2014)
✉ Email this page to a colleague
Amarin Pharma, Inc. v. Apotex, Inc. (N.D. Ill. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-04-24 |
Court | District Court, N.D. Illinois | Date Terminated | 2014-08-27 |
Cause | 35:271 Patent Infringement | Assigned To | James F. Holderman |
Jury Demand | None | Referred To | |
Patents | 8,293,728; 8,318,715; 8,357,677; 8,367,652; 8,377,920; 8,399,446; 8,415,335; 8,426,399; 8,431,560; 8,440,650; 8,501,225; 8,518,929; 8,524,698; 8,546,372; 8,551,521; 8,617,594 | ||
Firms | Stack & O'Connor Chartered | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Amarin Pharma, Inc. v. Apotex, Inc.
Details for Amarin Pharma, Inc. v. Apotex, Inc. (N.D. Ill. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2014-04-24 | 1 | of U.S. Patent No. 8,293,728 (“the ‘728 Patent”), U.S. Patent No. 8,318,715 (“the ‘715 Patent”), U.S.…36 above. 38. United States Patent No. 8,293,728, entitled “METHODS OF TREATING HYPERTRIGLYCERIDEMIA…U.S. Patent No. 8,357,677 (“the ‘677 Patent”), U.S. Patent No. 8,367,652 (“the ‘652 Patent”), U.S. Patent…,920 (“the ‘920 Patent”), U.S. Patent No. 8,399,446 (“the ‘446 Patent”), U.S. Patent No. 8,415,335 (“…(“the ‘335 Patent”), U.S. Patent No. 8,426,399 (“the ‘399 Patent”), U.S. Patent No. 8,431,560 (“the | External link to document | |
2014-04-30 | 7 | Amarin Pharmaceuticals Ireland Limited US 8,318,715 B2 11/27/2012 …451 Patent Number Date of Patent Holder of Patent US 8,617,594… MAILED patent report to Patent Trademark Office, Alexandria VA. (vcf, ) (Entered: 04/30/2014) … Apotex, Inc. PATENT NUMBER DATE OF PATENT … of 2 PageID #:450 TO: COMMISSIONER OF PATENTS AND TRADEMARKS (USPTO) | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |